首页|体外反搏联合心脏康复治疗慢性心力衰竭的疗效及其对线粒体标志物的影响

体外反搏联合心脏康复治疗慢性心力衰竭的疗效及其对线粒体标志物的影响

扫码查看
目的 研究体外反搏联合心脏康复治疗慢性心力衰竭的疗效及其对线粒体标志物的影响.方法 2022年1月至2023年1月期间在首都医科大学附属北京康复医院就诊的86例慢性心力衰竭患者按照随机数字表分为观察组和对照组,观察组接受常规抗心衰药物治疗及体外反搏联合心脏康复治疗,对照组接受常规抗心衰药物治疗.治疗前和治疗后36 d,检测心肌做功Tei指数、左心室射血分数(LVEF)、6分钟步行距离(6MWD)、明尼苏达心力衰竭生活质量调查表(MLHFQ)评分、日常生活活动能力(ADL)评分及血清线粒体转录因子A(TFAM)、线粒体偶联因子 6(CF6)水平;随访治疗后6个月的预后不良发生率和再入院率.结果 治疗后,观察组的Tei指数、LVEF、6MWD、ADL评分、血清TFAM水平高于对照组,差异有统计学意义(t=35.257、4.604、13.003、4.804、8.336,P<0.05),观察组的MLHFQ评分及血清CF6水平低于对照组,差异有统计学意义(t=12.233、7.967,P<0.05);随访6个月,观察组的预后不良发生率和再入院率均低于对照组,差异有统计意义(χ2=6.515、5.460,P<0.05).结论 体外反搏联合心脏康复治疗慢性心力衰竭提高心功能和生活质量,改善线粒体功能、调节线粒体标志物是与之相关的可能分子机制.
Effect of external counterpulsation combined with cardiac rehabilitation in treating chronic heart failure and its influence on mitochondrial markers
Objective To study the effect of external counterpulsation combined with cardiac reha-bilitation in treating chronic heart failure and its influence on mitochondrial markers.Methods From January 2022 to January 2023,86 patients with chronic heart failure were randomly divided into an observation group and a control group.The observation group received conventional anti-heart failure drug treatment along with external counterpulsation combined with cardiac rehabilitation treatment,while the control group only received conventional anti-heart failure treatment.Before and 36 days after treatment,measurements were taken for myocardial Tei index,left ventricular ejection fraction(LVEF),6-minute walking distance(6MWD),Min-nesota Heart Failure Quality of Life Questionnaire(MLHFQ)score,activity of daily living(ADL)score,and serum mitochondrial transcription factor A(TFAM)and mitochondrial coupling factor 6(CF6)levels.Follow-up was conducted to track the incidence of poor prognosis and readmission at 6 months after treatment.Results After treatment,the Tei index,LVEF,6MWD,ADL score and serum TFAM level in the observa-tion group were higher than those in the control group,the differences were statistically significant(t=35.257,4.604,13.003,4.804,8.336,P<0.05),The MLHFQ score and serum CF6 level in the observation group were lower than those in the control group,and the difference was statistically significant(t=12.233,7.967,P<0.05).After 6 months of follow-up,the incidence of poor prognosis and readmission rate in the observation group were lower than those in the control group,with statistically significant difference(χ2=6.515,5.460,P<0.05).Conclusion Extracorporeal counterpulsation,when combined with cardiac rehabilitation improves car-diac function and quality of life in the treatment of chronic heart failure.The improvement of mitochondrial function and regulation of mitochondrial markers are possible molecular mechanisms involved.

Chronic heart failureExternal counterpulsationCardiac rehabilitationCardiac functionMitochondrial function

孙晓静、王立中、张振英、张柳、许志萍、杨澄

展开 >

首都医科大学附属北京康复医院,北京 100144

慢性心力衰竭 体外反搏 心脏康复 心功能 线粒体功能

首都医科大学附属北京康复医院科研发展专项

2021-036

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(5)
  • 4